Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01523977
Title Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

acute lymphoblastic leukemia

Therapies

Prednisone

Everolimus

Vincristine Sulfate

Doxorubicin

Pegaspargase

Age Groups: child
Covered Countries USA


No variant requirements are available.